发明名称 |
R(+)-N-METHYL-PROPARGYL-AMINOINDAN. |
摘要 |
The subject invention provides R(+)-N-methyl-propargylaminoindan or a pharmaceutically acceptable salt thereof and a composition containing R(+)-N-propargyl-1(R)-aminoindan or a pharmaceutically acceptable salt thereof and a compound of R(+)-N-methyl-propargyl-aminoindan or a salt thereof. Also disclosed are methods of validating a batch of rasagiline for use in a pharmaceutical formulation and a method of validating a rasagiline formulation for distribution, based on the content of R(+)-N-methyl -propargyl-aminoindan or a salt thereof. |
申请公布号 |
MX2014004201(A) |
申请公布日期 |
2015.01.12 |
申请号 |
MX20140004201 |
申请日期 |
2012.10.09 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
RAMY LIDOR-HADAS;MUHAMMAD SAFADI;RACHEL COHEN;ANTON FRENKEL;MICHAL KEISAR;DANIT LICHT;ELIEZER BAHAR;MARINA ZHOLKOVSKY |
分类号 |
A61K31/135 |
主分类号 |
A61K31/135 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|